OTCMKTS:SHWZ - Medicine Man Technologies Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $4.00
  • Forecasted Upside: 102.02 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$1.98
▼ -0.02 (-1.00%)

This chart shows the closing price for SHWZ by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Medicine Man Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SHWZ and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SHWZ

Analyst Price Target is $4.00
▲ +102.02% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Medicine Man Technologies in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 102.02% upside from the last price of $1.98.

This chart shows the closing price for SHWZ for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in Medicine Man Technologies.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/20/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/20/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/18/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/17/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/16/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/27/2020Noble FinancialReiterated RatingBuy$4.00
(Data available from 9/16/2016 forward)

News Sentiment Rating

0.84 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/18/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/20/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/19/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/19/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/18/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/18/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/17/2021
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/16/2021

Current Sentiment

  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Medicine Man Technologies logo
Medicine Man Technologies, Inc. engages in the provision of advisory and consulting services related to cannabis cultivation. It operates through the following segments: Products; Licensing and Consulting; And Corporate, Infrastructure, and Other. The Products segment sells merchandise directly to customers via e-commerce portals, through the proprietary websites and retail location. The Licensing and Consulting segment refers to the licensing and consulting agreements with cannabis related entities. The Corporate, Infrastructure, and Other segment relates to the new resources added in anticipation of various acquisition transactions and other corporate related costs. The company was founded by Andrew Williams on March 20, 2014 and is headquartered in Denver, CO.
Read More

Today's Range

Now: $1.98
Low: $1.95
High: $2.01

50 Day Range

MA: $2.22
Low: $1.98
High: $2.38

52 Week Range

Now: $1.98
Low: $1.07
High: $3.25

Volume

17,290 shs

Average Volume

117,825 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Medicine Man Technologies?

The following equities research analysts have issued research reports on Medicine Man Technologies in the last twelve months: Noble Financial.
View the latest analyst ratings for SHWZ.

What is the current price target for Medicine Man Technologies?

1 Wall Street analysts have set twelve-month price targets for Medicine Man Technologies in the last year. Their average twelve-month price target is $4.00, suggesting a possible upside of 102.0%. Noble Financial has the highest price target set, predicting SHWZ will reach $4.00 in the next twelve months. Noble Financial has the lowest price target set, forecasting a price of $4.00 for Medicine Man Technologies in the next year.
View the latest price targets for SHWZ.

What is the current consensus analyst rating for Medicine Man Technologies?

Medicine Man Technologies currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SHWZ will outperform the market and that investors should add to their positions of Medicine Man Technologies.
View the latest ratings for SHWZ.

What other companies compete with Medicine Man Technologies?

Other companies that are similar to Medicine Man Technologies include AllyMe Group, ALS, American Cannabis, Igeamed, Intertek Group, SGD and Teleperformance.

How do I contact Medicine Man Technologies' investor relations team?

The company's listed phone number is (303) 371-0387. The official website for Medicine Man Technologies is www.schwazze.com.